Idenix Names Weidenbruch General Counsel

Article

Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.

Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel. Before joining Idenix, Weidenbruch served as general counsel at Abraxis BioScience Inc. and in various legal roles at Amgen.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Daniel Fischer, Tevard
Junevity Co-founder & CEO, John Hoekman, PhD
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.